Publications
- WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience2021 | First Faculty of Medicine
- Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis2013 | First Faculty of Medicine
- ABC transporters are predictors of treatment failure in acute myeloid leukaemia2024 | First Faculty of Medicine, Faculty of Science
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome2023 | First Faculty of Medicine
- Tyrosinkinázové inhibitory tří generací v léčbě akutní lymfoblastové leukemie dospělých2023 | First Faculty of Medicine
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | First Faculty of Medicine, Second Faculty of Medicine
- A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel2022 | First Faculty of Medicine, Faculty of Science
- NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia2022 | First Faculty of Medicine
Loading network view...